Friday, November 30, 2018 12:20:36 PM
1. Continue to strengthen alliances and sales overseas.
2. Culminate a deal with Dr. Scholls if the divestiture from Bayer doesn't affect it. If it does, put our product back on the market and look for partners to do so with. Who knows, maybe CVS would be a good candidate, an approved product ready to go.
3. Work with CVS for full exposure in all stores.
4. Pursue Allay full bore.
5. Pursue approval for use by women for general pain applications full bore.
6. Continue to find new areas of possibility.
Nothing is foolproof to a sufficently talented fool !!
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM